{"hands_on_practices": [{"introduction": "To master the hormonal control of osmoregulation, we must first master the language of osmotic pressure. This foundational exercise prompts you to calculate the osmolarity of a solution, a direct measure of its total concentration of osmotically active particles. This essential skill is the starting point for understanding the gradients that drive water movement and for precisely preparing the experimental solutions used to study physiological responses in both animals and plants [@problem_id:2582071].", "problem": "In comparative studies of osmoregulation across animals and plants, investigators often benchmark external solutions against the effective osmole load detected by vertebrate hypothalamic osmoreceptors that regulate Antidiuretic Hormone (ADH) and the Renin–Angiotensin–Aldosterone System (RAAS). While plants lack ADH and RAAS, they also respond to extracellular osmotic conditions through their own hormonal networks, making precise control of extracellular osmoles critical for cross-kingdom experiments. Consider an experimental extracellular solution at $37\\,^{\\circ}\\mathrm{C}$ formulated to be compatible with vertebrate plasma and plant apoplast. The solution contains sodium chloride at $140\\,\\mathrm{mM}$ and glucose at $10\\,\\mathrm{mM}$. Assume sodium chloride dissociates completely into sodium and chloride ions, glucose does not dissociate, and that nonideal interactions are negligible so the mixture behaves ideally for the purpose of counting osmotically active particles.\n\nUsing only fundamental definitions of osmotic particles and additivity of independent solute contributions under ideal conditions, determine the osmolarity of this solution. Express the final osmolarity in milliosmoles per liter ($\\mathrm{mOsm\\,L^{-1}}$) and round your answer to three significant figures. Provide only the numerical value in your final boxed answer without units.", "solution": "The problem statement is submitted for validation.\n\nFirst, the givens are extracted verbatim as required.\n- Temperature: $37\\,^{\\circ}\\mathrm{C}$\n- Sodium chloride concentration: $140\\,\\mathrm{mM}$\n- Glucose concentration: $10\\,\\mathrm{mM}$\n- Assumption 1: Sodium chloride dissociates completely into sodium and chloride ions.\n- Assumption 2: Glucose does not dissociate.\n- Assumption 3: Nonideal interactions are negligible (ideal solution behavior).\n- Task: Determine the osmolarity of the solution in $\\mathrm{mOsm\\,L^{-1}}$.\n- Rounding: Three significant figures.\n\nNext, these givens are subjected to validation. The problem is scientifically grounded, as it concerns the fundamental concept of osmolarity, a cornerstone of physical chemistry and physiology. The concentrations of sodium chloride and glucose are within physiological ranges for vertebrate plasma, making the experimental context realistic. The problem is well-posed; it provides all necessary information (solute concentrations and dissociation behavior) and a clear objective. The assumptions of complete dissociation and ideal behavior are standard simplifications for such introductory calculations, rendering the problem solvable with a unique, meaningful answer. The language is objective and precise. The problem is not incomplete, contradictory, or ill-posed. The inclusion of temperature ($37\\,^{\\circ}\\mathrm{C}$) is common in physiological problems but is extraneous to the calculation of osmolarity, which is a measure of solute particle concentration, not osmotic pressure. This does not invalidate the problem but requires recognition of its irrelevance to the specific question asked.\n\nThe verdict is that the problem is valid. A solution will be furnished.\n\nThe osmolarity of a solution is defined as the total concentration of all osmotically active solute particles. For an ideal solution containing multiple non-interacting solutes, the total osmolarity is the sum of the osmolar contributions of each individual solute.\n\nThe contribution of a solute to the total osmolarity is the product of its molar concentration, $C$, and its van 't Hoff factor, $i$, which represents the number of distinct particles the solute produces upon dissolution. The total osmolarity, $\\Pi_{total}$, is thus given by the formula:\n$$ \\Pi_{total} = \\sum_{k} i_k C_k $$\nwhere the sum is over all solutes $k$ in the solution.\n\nThe solution contains two solutes: sodium chloride ($\\mathrm{NaCl}$) and glucose. We will calculate the contribution of each.\n\n1.  Sodium Chloride ($\\mathrm{NaCl}$):\n    The molar concentration of $\\mathrm{NaCl}$ is given as $C_{\\mathrm{NaCl}} = 140\\,\\mathrm{mM}$.\n    The problem states that $\\mathrm{NaCl}$ dissociates completely in solution. The dissociation reaction is:\n    $$ \\mathrm{NaCl} \\rightarrow \\mathrm{Na}^{+} + \\mathrm{Cl}^{-} $$\n    For each mole of $\\mathrm{NaCl}$ that dissolves, two moles of osmotically active particles are produced: one mole of sodium ions ($\\mathrm{Na}^{+}$) and one mole of chloride ions ($\\mathrm{Cl}^{-}$). Therefore, the van 't Hoff factor for $\\mathrm{NaCl}$ under these ideal conditions is $i_{\\mathrm{NaCl}} = 2$.\n    The osmolar contribution from $\\mathrm{NaCl}$ is:\n    $$ \\Pi_{\\mathrm{NaCl}} = i_{\\mathrm{NaCl}} \\times C_{\\mathrm{NaCl}} = 2 \\times 140\\,\\mathrm{mOsm\\,L^{-1}} = 280\\,\\mathrm{mOsm\\,L^{-1}} $$\n\n2.  Glucose:\n    The molar concentration of glucose is given as $C_{\\mathrm{glucose}} = 10\\,\\mathrm{mM}$.\n    The problem states that glucose, a non-electrolyte, does not dissociate in solution.\n    Therefore, for each mole of glucose that dissolves, one mole of osmotically active particles is produced. The van 't Hoff factor for glucose is $i_{\\mathrm{glucose}} = 1$.\n    The osmolar contribution from glucose is:\n    $$ \\Pi_{\\mathrm{glucose}} = i_{\\mathrm{glucose}} \\times C_{\\mathrm{glucose}} = 1 \\times 10\\,\\mathrm{mOsm\\,L^{-1}} = 10\\,\\mathrm{mOsm\\,L^{-1}} $$\n\nThe total osmolarity of the solution is the sum of the individual contributions:\n$$ \\Pi_{total} = \\Pi_{\\mathrm{NaCl}} + \\Pi_{\\mathrm{glucose}} $$\n$$ \\Pi_{total} = 280\\,\\mathrm{mOsm\\,L^{-1}} + 10\\,\\mathrm{mOsm\\,L^{-1}} = 290\\,\\mathrm{mOsm\\,L^{-1}} $$\n\nThe calculated value is $290$. This number has three significant figures ($2$, $9$, and $0$), so no further rounding is required. The given temperature of $37\\,^{\\circ}\\mathrm{C}$ is not used in this calculation, as osmolarity is a measure of concentration, not osmotic pressure.", "answer": "$$\n\\boxed{290}\n$$", "id": "2582071"}, {"introduction": "Having established the fundamental concept of osmolarity, we now explore the intricate molecular machinery that responds to osmotic changes. This thought experiment challenges you to deduce the systemic consequences of a single, precise molecular defect in the Antidiuretic Hormone (ADH) signaling pathway [@problem_id:2582083]. By reasoning from the failure of Aquaporin-2 phosphorylation to the resulting renal and systemic phenotype, you will develop a deep, mechanistic appreciation for how cellular signal transduction governs whole-organism water balance.", "problem": "A comparative physiologist investigates how water balance is hormonally controlled across taxa. In mammals, final urine concentration depends on the water permeability of principal cells in the collecting duct, which is normally low and increases rapidly when Antidiuretic Hormone (ADH) binds the vasopressin V$2$ receptor (V$2$R). The canonical, well-tested sequence is: ADH binds basolateral V$2$R on principal cells, the stimulatory G protein activates adenylate cyclase, cyclic adenosine monophosphate rises, Protein Kinase A (PKA) is activated, and PKA phosphorylates Aquaporin $2$ (AQP$2$) at defined serine residues, which increases AQP$2$ trafficking to and retention at the apical membrane. With a hypertonic medullary interstitium intact, increased apical water permeability allows osmotic water reabsorption and thus concentrated urine. The Renin-Angiotensin-Aldosterone System (RAAS) responds to effective circulating volume decreases by increasing sodium reabsorption and thirst, but it does not directly replace ADH-dependent apical water channels in the collecting duct. In plants, aquaporins (e.g., Plasma membrane Intrinsic Proteins) are also regulated by phosphorylation and pH, but there is no vasopressin system; instead, phytohormones and cellular signaling modulate aquaporin gating to influence cell and tissue hydraulics.\n\nA transgenic mammalian model is engineered in which AQP$2$ carries a substitution at Serine $256$ (Ser$256$) that prevents phosphorylation at this site (for example, Ser$256$ to Alanine, S$256$A). The V$2$R, G protein, adenylate cyclase, and PKA are intact and functional; the renal medullary osmotic gradient is preserved; basolateral Aquaporin $3$ and Aquaporin $4$ are normal. Animals are water-restricted to activate endogenous ADH and then given a pharmacologic challenge with exogenous desmopressin (a selective V$2$R agonist). Based only on the fundamental mechanisms summarized above, which outcome best predicts the renal concentrating phenotype and the response to exogenous desmopressin in this model, including the expected direction of RAAS activity?\n\nA. Severe nephrogenic diabetes insipidus with very low urine osmolality during water restriction, no meaningful rise (less than $10\\%$) in urine osmolality after desmopressin, high endogenous ADH, and activated RAAS secondary to hypovolemia.\n\nB. Partial central diabetes insipidus with modestly low baseline urine osmolality that normalizes after desmopressin (greater than $50\\%$ increase), suppressed endogenous ADH, and low renin-angiotensin activity.\n\nC. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)-like state with high urine osmolality without desmopressin, hyponatremia, no change with desmopressin, and suppressed RAAS.\n\nD. Salt-wasting nephropathy with medullary washout causing low urine osmolality that is substantially corrected by desmopressin, and suppressed RAAS due to extracellular fluid expansion.\n\nE. Mild concentrating defect that partially improves with desmopressin because proximal tubule aquaporins compensate for the collecting duct deficit, with minimal RAAS activation.", "solution": "The problem statement will first be validated for scientific and logical integrity.\n\n**Step 1: Extraction of Givens**\n-   **System**: Mammalian hormonal control of water balance.\n-   **Key Hormones/Systems**: Antidiuretic Hormone (ADH), Renin-Angiotensin-Aldosterone System (RAAS).\n-   **Cellular Mechanism of ADH Action**:\n    -   ADH binds basolateral vasopressin V$2$ receptor ($V_2R$) on collecting duct principal cells.\n    -   Stimulatory G protein activates adenylate cyclase.\n    -   Cyclic adenosine monophosphate ($cAMP$) concentration rises.\n    -   Protein Kinase A ($PKA$) is activated.\n    -   $PKA$ phosphorylates Aquaporin $2$ ($AQP2$) at defined serine residues.\n    -   Phosphorylated $AQP2$ is trafficked to and retained at the apical membrane.\n    -   This increases apical water permeability, allowing osmotic water reabsorption into a hypertonic medullary interstitium.\n-   **RAAS Function**: Responds to decreased effective circulating volume by increasing sodium reabsorption and thirst. It does not directly provide apical water channels.\n-   **Experimental Model**: A transgenic mammal with a specific genetic modification.\n    -   **Mutation**: Aquaporin $2$ ($AQP2$) has a substitution at Serine $256$ ($Ser256$) that prevents its phosphorylation (e.g., $S256A$).\n    -   **Intact Components**: The $V_2R$, G protein, adenylate cyclase, and $PKA$ are functional.\n    -   **Preserved Conditions**: The renal medullary osmotic gradient is intact. Basolateral Aquaporin $3$ ($AQP3$) and Aquaporin $4$ ($AQP4$) are normal.\n-   **Experimental Protocol**:\n    -   Animals are water-restricted to induce endogenous ADH release.\n    -   A subsequent challenge with exogenous desmopressin (a selective $V_2R$ agonist) is administered.\n-   **Question**: Predict the renal concentrating phenotype, the response to desmopressin, and the status of RAAS activity in this model.\n\n**Step 2: Validation of Problem Statement**\n-   **Scientific Grounding**: The problem statement is scientifically sound. The described ADH-cAMP-PKA-AQP$2$ signaling cascade is the canonical, well-established mechanism for regulating water permeability in the mammalian collecting duct. The role of $PKA$-mediated phosphorylation of $AQP2$ at $Ser256$ is critical for its apical membrane translocation and is a cornerstone of modern renal physiology. The experimental model, a site-directed mutation preventing phosphorylation, is a standard and valid method for investigating protein function. The functions of RAAS, desmopressin, and the conditions of water restriction are all described accurately.\n-   **Well-Posedness**: The problem is well-posed. It presents a clear initial state (genetic modification) and a set of established rules (physiological mechanisms), then asks for the logical deduction of the system's behavior under specific stimuli. The provided information is sufficient and necessary to arrive at a unique, predictable outcome.\n-   **Objectivity and Completeness**: The problem is stated in objective, technical language. It avoids ambiguity by explicitly stating which components are functional (e.g., \"$V_2R...PKA$ are intact\") and which conditions are maintained (e.g., \"medullary osmotic gradient is preserved\"). This removes confounding variables and allows for a focused analysis of the specified defect.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. It is a rigorous and well-formulated question in cellular and systems physiology. Proceeding to solution derivation.\n\n**Derivation of Solution**\nThe central defect in the transgenic model is the inability to phosphorylate $AQP2$ at serine $256$. According to the provided mechanism, this phosphorylation is an obligatory step for the trafficking of $AQP2$ water channels to the apical plasma membrane of the principal cells in the collecting duct.\n\n$1$. **Analysis of the Molecular Defect**: The signaling cascade upstream of $PKA$ is intact. Water restriction elevates endogenous ADH levels, and subsequent administration of desmopressin further stimulates the $V_2R$. This leads to activation of adenylate cyclase, production of $cAMP$, and activation of $PKA$. However, when the activated $PKA$ attempts to phosphorylate its substrate, $AQP2$, at the critical $Ser256$ residue, it fails because the site has been mutated (e.g., to alanine, which lacks a hydroxyl group for phosphorylation). Consequently, despite a strong upstream signal, $AQP2$ remains in intracellular vesicles and is not inserted into the apical membrane. The collecting duct remains impermeable to water.\n\n$2$. **Prediction of Physiological State**:\n-   **Renal Concentrating Ability**: Since the collecting duct is impermeable to water, the kidney cannot reabsorb water from the tubular fluid in response to the medullary osmotic gradient. The organism is unable to produce concentrated urine. This leads to the excretion of large volumes of dilute urine (polyuria). The inability of the kidney to respond to ADH is the definition of **nephrogenic diabetes insipidus (NDI)**. Because the mutation blocks the final essential step, the defect is severe.\n-   **Response to Desmopressin**: Desmopressin is a $V_2R$ agonist. It mimics the action of endogenous ADH. Since the defect is located downstream of the receptor and its signaling cascade (at the level of the target protein $AQP2$ itself), adding more agonist will not overcome the block. The urine osmolality will therefore show no significant increase after the desmopressin challenge.\n-   **Systemic Homeostasis**: The massive obligatory water loss (polyuria) leads to dehydration. This results in an increase in plasma osmolality (hyperosmolality) and a decrease in effective circulating blood volume (hypovolemia). Hyperosmolality is a potent stimulus for ADH secretion from the pituitary, so endogenous ADH levels will be high. Hypovolemia is the primary stimulus for the activation of the **Renin-Angiotensin-Aldosterone System (RAAS)**. Thus, renin, angiotensin II, and aldosterone levels will be elevated.\n\n**Evaluation of Options**\n\n**A. Severe nephrogenic diabetes insipidus with very low urine osmolality during water restriction, no meaningful rise (less than $10\\%$) in urine osmolality after desmopressin, high endogenous ADH, and activated RAAS secondary to hypovolemia.**\nThis option accurately describes the deduced phenotype. The term \"nephrogenic diabetes insipidus\" is correct because the kidney fails to respond to ADH. The defect is severe. Urine osmolality will be very low despite water restriction. There will be no meaningful response to desmopressin (a rise of less than $10\\%$ is consistent with this). High endogenous ADH is the correct compensatory response to hyperosmolality. Activated RAAS is the correct compensatory response to hypovolemia.\n**Verdict: Correct.**\n\n**B. Partial central diabetes insipidus with modestly low baseline urine osmolality that normalizes after desmopressin (greater than $50\\%$ increase), suppressed endogenous ADH, and low renin-angiotensin activity.**\nThis option is incorrect. \"Central\" diabetes insipidus implies a lack of ADH secretion, but the problem specifies high endogenous ADH and a defect in the kidney (\"nephrogenic\"). The urine osmolality would not normalize after desmopressin. ADH and RAAS would be high, not suppressed.\n**Verdict: Incorrect.**\n\n**C. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)-like state with high urine osmolality without desmopressin, hyponatremia, no change with desmopressin, and suppressed RAAS.**\nThis option describes the opposite condition. An SIADH-like state would require constitutive, ADH-independent water reabsorption, leading to water retention, concentrated urine, and hyponatremia. The $S256A$ mutation is a loss-of-function, causing water loss, not retention. RAAS would be activated, not suppressed.\n**Verdict: Incorrect.**\n\n**D. Salt-wasting nephropathy with medullary washout causing low urine osmolality that is substantially corrected by desmopressin, and suppressed RAAS due to extracellular fluid expansion.**\nThis option is incorrect. The primary defect is in water transport, not salt transport. The problem explicitly states the medullary gradient is preserved, ruling out \"medullary washout\" as the primary cause. The concentrating defect is not corrected by desmopressin. The animal experiences volume depletion (hypovolemia), not expansion, so RAAS would be activated.\n**Verdict: Incorrect.**\n\n**E. Mild concentrating defect that partially improves with desmopressin because proximal tubule aquaporins compensate for the collecting duct deficit, with minimal RAAS activation.**\nThis option is incorrect. The defect is severe, not mild, as it blocks the regulated pathway. It will not improve with desmopressin. Proximal tubule water reabsorption (via $AQP1$) is largely constitutive and iso-osmotic; it cannot compensate for the loss of regulated, hyperosmotic water reabsorption in the collecting duct, which is required for concentrating urine. The resulting severe volume loss would cause strong, not minimal, RAAS activation.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "2582083"}, {"introduction": "While ADH finely tunes water permeability, the Renin-Angiotensin-Aldosterone System (RAAS) serves as the master regulator of sodium balance and, consequently, long-term blood volume and pressure. This problem transitions our focus to the RAAS, presenting a quantitative model of how Angiotensin II modulates sodium transport in the proximal tubule [@problem_id:2581959]. By calculating the change in fractional reabsorption, you will practice applying concepts like rate-limiting steps and sensitivity analysis, which are crucial tools for modeling complex physiological systems.", "problem": "A vertebrate proximal tubule reabsorbs sodium primarily via an apical sodium-hydrogen exchanger isoform 3 (NHE3) in series with a basolateral sodium-potassium adenosine triphosphatase (Na$^+$/K$^+$-ATPase). In steady state, mass conservation requires that net transepithelial sodium reabsorption equals apical influx and equals basolateral efflux. Assume the following fundamental base: (i) at a fixed luminal and intracellular ionic milieu, the apical and basolateral sodium fluxes near their operating point scale proportionally with their respective maximal catalytic capacities, so that a first-order linearization around the baseline is valid; (ii) the rate-limiting step for a series process is the smaller of the two capacities. Consider that the renin-angiotensin-aldosterone system (RAAS) increases angiotensin II (Ang II), which activates the angiotensin II type 1 receptor (AT1) to upregulate both NHE3 and Na$^+$/K$^+$-ATPase activities through increased membrane abundance and phosphorylation-dependent activation. By contrast, antidiuretic hormone (ADH) primarily targets distal nephron segments and is held constant here. For comparative context, in land plants, abscisic acid (ABA) modulates osmotic adjustments through proton pumps and cation transporters in roots; however, plants lack RAAS, and the calculation below pertains to the vertebrate kidney.\n\nLet the fractional activation of AT1 be $a$, with a baseline $a_{0} = 0.3$ and a stimulated state $a_{1} = 0.5$. Let the apical NHE3 maximal capacity $V_{\\mathrm{NHE3}}$ and the basolateral Na$^+$/K$^+$-ATPase maximal capacity $V_{\\mathrm{pump}}$ change linearly with AT1 activation around baseline according to\n$$V_{\\mathrm{NHE3}}(a) = V_{\\mathrm{NHE3}}^{0}\\left[1 + \\eta_{a}\\left(a - a_{0}\\right)\\right], \\quad V_{\\mathrm{pump}}(a) = V_{\\mathrm{pump}}^{0}\\left[1 + \\eta_{b}\\left(a - a_{0}\\right)\\right],$$\nwhere $V_{\\mathrm{NHE3}}^{0}$ and $V_{\\mathrm{pump}}^{0}$ are the baseline values at $a_{0}$, $\\eta_{a} = 1.0$, and $\\eta_{b} = 0.8$. Assume that at baseline the apical and basolateral capacities are matched such that the steady-state sodium flux $J_{0}$ through the proximal tubule equals both the apical and basolateral capacities at $a_{0}$. Assume that the filtered sodium load remains constant because glomerular filtration rate and plasma sodium concentration are unchanged, and that ADH and downstream segments do not alter sodium handling during the maneuver.\n\nThe proximal tubular fractional reabsorption of filtered sodium at baseline is $F\\!R_{0} = 0.62$ (unitless fraction). Using the principles above and the provided parameters, compute the new proximal tubular fractional reabsorption $F\\!R_{1}$ (unitless fraction) after the increase in AT1 activation from $a_{0}$ to $a_{1}$. Express your answer as a unitless decimal fraction, and round your answer to four significant figures.", "solution": "The problem is determined to be valid as it is scientifically grounded, well-posed, and contains all necessary information for a unique solution.\n\nThe fractional reabsorption of sodium, $F\\!R$, in the proximal tubule is defined as the ratio of the net reabsorptive sodium flux, $J$, to the filtered sodium load, $L_{\\mathrm{Na}^{+}}$.\n$$F\\!R = \\frac{J}{L_{\\mathrm{Na}^{+}}}$$\nThe problem states that the filtered sodium load remains constant. Consequently, the fractional reabsorption is directly proportional to the sodium flux, $J$.\n$$F\\!R \\propto J$$\nThis proportionality allows us to relate the fractional reabsorption in the baseline state ($F\\!R_0$) to that in the stimulated state ($F\\!R_1$) through the corresponding fluxes ($J_0$ and $J_1$):\n$$\\frac{F\\!R_1}{F\\!R_0} = \\frac{J_1}{J_0} \\implies F\\!R_1 = F\\!R_0 \\frac{J_1}{J_0}$$\nThe problem specifies that transepithelial sodium transport is a series process involving apical and basolateral steps, and that the net flux is limited by the smaller of the two maximal capacities, $V_{\\mathrm{NHE3}}$ and $V_{\\mathrm{pump}}$.\n$$J = \\min\\left(V_{\\mathrm{NHE3}}, V_{\\mathrm{pump}}\\right)$$\nAt baseline, AT$1$ activation is $a_0 = 0.3$. The capacities are $V_{\\mathrm{NHE3}}^0$ and $V_{\\mathrm{pump}}^0$. It is given that these are matched, i.e., $V_{\\mathrm{NHE3}}^0 = V_{\\mathrm{pump}}^0$. Let us denote this common baseline capacity as $V^0$. The baseline flux $J_0$ is therefore:\n$$J_0 = \\min\\left(V_{\\mathrm{NHE3}}^0, V_{\\mathrm{pump}}^0\\right) = \\min\\left(V^0, V^0\\right) = V^0$$\nThis is consistent with the given information that $J_0$ equals both baseline capacities.\n\nIn the stimulated state, AT$1$ activation increases to $a_1 = 0.5$. The new capacities, $V_{\\mathrm{NHE3}}(a_1)$ and $V_{\\mathrm{pump}}(a_1)$, are calculated using the provided linear models:\n$$V_{\\mathrm{NHE3}}(a_1) = V_{\\mathrm{NHE3}}^{0}\\left[1 + \\eta_{a}\\left(a_1 - a_{0}\\right)\\right] = V^0\\left[1 + \\eta_{a}\\left(a_1 - a_{0}\\right)\\right]$$\n$$V_{\\mathrm{pump}}(a_1) = V_{\\mathrm{pump}}^{0}\\left[1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right] = V^0\\left[1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right]$$\nThe new flux, $J_1$, is the minimum of these two new capacities:\n$$J_1 = \\min\\left(V_{\\mathrm{NHE3}}(a_1), V_{\\mathrm{pump}}(a_1)\\right)$$\n$$J_1 = \\min\\left(V^0\\left[1 + \\eta_{a}\\left(a_1 - a_{0}\\right)\\right], V^0\\left[1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right]\\right)$$\nSince $V^0$ is a positive constant, it can be factored out of the minimum operator:\n$$J_1 = V^0 \\min\\left(1 + \\eta_{a}\\left(a_1 - a_{0}\\right), 1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right)$$\nNow we can compute the ratio $J_1 / J_0$:\n$$\\frac{J_1}{J_0} = \\frac{V^0 \\min\\left(1 + \\eta_{a}\\left(a_1 - a_{0}\\right), 1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right)}{V^0} = \\min\\left(1 + \\eta_{a}\\left(a_1 - a_{0}\\right), 1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right)$$\nThe new fractional reabsorption $F\\!R_1$ is then:\n$$F\\!R_1 = F\\!R_0 \\min\\left(1 + \\eta_{a}\\left(a_1 - a_{0}\\right), 1 + \\eta_{b}\\left(a_1 - a_{0}\\right)\\right)$$\nWe substitute the given numerical values: $F\\!R_0 = 0.62$, $a_0 = 0.3$, $a_1 = 0.5$, $\\eta_a = 1.0$, and $\\eta_b = 0.8$.\nThe change in activation is $\\Delta a = a_1 - a_0 = 0.5 - 0.3 = 0.2$.\nThe two terms inside the minimum function are:\n$$1 + \\eta_a \\Delta a = 1 + (1.0)(0.2) = 1 + 0.2 = 1.2$$\n$$1 + \\eta_b \\Delta a = 1 + (0.8)(0.2) = 1 + 0.16 = 1.16$$\nThe minimum of these two values is:\n$$\\min(1.2, 1.16) = 1.16$$\nThis indicates that the basolateral pump, which has the lower sensitivity $\\eta_b$, becomes the rate-limiting step after the stimulation.\nFinally, we compute $F\\!R_1$:\n$$F\\!R_1 = F\\!R_0 \\times 1.16 = 0.62 \\times 1.16 = 0.7192$$\nThe problem requires the answer to be rounded to four significant figures. The result $0.7192$ already is presented with four significant figures.", "answer": "$$\n\\boxed{0.7192}\n$$", "id": "2581959"}]}